CSPC PHARMA (01093) adopts a stock incentive plan for 2026.

CSPC PHARMA (01093) announced that, due to the total number of shares purchased in the market under the terms and conditions of the 2018 Share Incentive Plan nearing the limit of the plan (i.e. not exceeding 2% of the total number of shares issued by the company as of August 20, 2018), the Board of Directors gladly announces that a resolution has been passed to adopt the 2026 Share Incentive Plan on March 25, 2026. After amending the terms of the 2018 Share Incentive Plan on May 21, 2024, the Board of Directors can only instruct the trustee to purchase existing shares in the market to fulfill the share incentives granted under the 2018 Share Incentive Plan. Since the adoption of the 2018 Share Incentive Plan in 2018, the share incentives granted under the plan have not been met through the issuance or distribution of new shares. As of the date of this announcement, the number of shares available for future grants under the 2018 Share Incentive Plan is approximately 64.0199 million shares, while the share incentives already granted but not yet vested under the plan amount to 53.3185 million shares. The 2018 Share Incentive Plan will continue to be in full force and effect until it expires on August 19, 2028 (i.e. 10 years from the adoption date), and will not affect the existing rights of the selected participants under the 2018 Share Incentive Plan.